Farther Finance Advisors »

Karyopharm Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $81 66 1.23

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Vanguard Morningstar Value Etf Etf (VTV)
Microsoft Corp Stock (MSFT)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Qqq Trust Series I Etf (QQQ)

View all positions for Farther Finance Advisors

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics